Search research articles
Contact Us
Filters
Showing results (71-80 of 170) with videos related to
Page
of 17
Sort By:
World Journal of Urology
|
January 7, 2022
Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG)
Christoph Seidel, Marcus Hentrich, Stefanie Zschäbitz, et al.
BJUI Compass
|
September 17, 2025
Perioperative chemotherapy use and related outcomes in muscle-invasive bladder cancer in Australia
Alison Hiong, James Lynam, Andrew Weickhardt, et al.
Immunotherapy
|
September 12, 2024
A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumors
Ben Tran, Mark Voskoboynik, Johanna Bendell, et al.
Asia-Pacific Journal of Clinical Oncology
|
October 31, 2017
Precision oncology using a clinician-directed, tailored approach to molecular profiling
Michael Lam, Ben Tran, Sophie Beck, et al.
Asia-Pacific Journal of Clinical Oncology
|
January 31, 2022
Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis
Grace Chazan, Angelyn Anton, Shirley Wong, et al.
European Urology
|
November 5, 2019
Indirect Comparisons of Efficacy between Combination Approaches in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis
Niranjan J Sathianathen, Samantha Koschel, Isaac A Thangasamy, et al.
International Journal of Cancer
|
March 17, 2021
Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting
Louise Kostos, Wei Hong, Belinda Lee, et al.
Cancer Discovery
|
September 23, 2021
Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring <i>FGF</i>/<i>FGFR</i> Aberrations: A Phase I Dose-Expansion Study
Funda Meric-Bernstam, Rastislav Bahleda, Cinta Hierro, et al.
Cancers
|
September 9, 2022
Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities
Belinda Lee, Lucy Gately, Sheau Wen Lok, et al.
Oncology Research and Treatment
|
September 13, 2021
A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events
Patrick Schöffski, Nicole Concin, Cristina Suarez, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 170) with videos related to
Sort By:
Page
of 17
World Journal of Urology
|
January 7, 2022
Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG)
Christoph Seidel, Marcus Hentrich, Stefanie Zschäbitz, et al.
BJUI Compass
|
September 17, 2025
Perioperative chemotherapy use and related outcomes in muscle-invasive bladder cancer in Australia
Alison Hiong, James Lynam, Andrew Weickhardt, et al.
Immunotherapy
|
September 12, 2024
A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumors
Ben Tran, Mark Voskoboynik, Johanna Bendell, et al.
Asia-Pacific Journal of Clinical Oncology
|
October 31, 2017
Precision oncology using a clinician-directed, tailored approach to molecular profiling
Michael Lam, Ben Tran, Sophie Beck, et al.
Asia-Pacific Journal of Clinical Oncology
|
January 31, 2022
Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis
Grace Chazan, Angelyn Anton, Shirley Wong, et al.
European Urology
|
November 5, 2019
Indirect Comparisons of Efficacy between Combination Approaches in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis
Niranjan J Sathianathen, Samantha Koschel, Isaac A Thangasamy, et al.
International Journal of Cancer
|
March 17, 2021
Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting
Louise Kostos, Wei Hong, Belinda Lee, et al.
Cancer Discovery
|
September 23, 2021
Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring <i>FGF</i>/<i>FGFR</i> Aberrations: A Phase I Dose-Expansion Study
Funda Meric-Bernstam, Rastislav Bahleda, Cinta Hierro, et al.
Cancers
|
September 9, 2022
Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities
Belinda Lee, Lucy Gately, Sheau Wen Lok, et al.
Oncology Research and Treatment
|
September 13, 2021
A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events
Patrick Schöffski, Nicole Concin, Cristina Suarez, et al.
Page
of 17